The prospects of cariprazine in the treatment of schizophrenia

被引：6
|
作者：
Scarff, Jonathan R. [1 ]
机构：
[1] Dept Vet Affairs, Community Based Outpatient Clin, 279 North Grove Med Pk Dr, Spartanburg, SC 29303 USA
来源：
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 2017年 / 7卷 / 11期
关键词：
RECEPTOR PARTIAL AGONIST; NEGATIVE SYMPTOMS; MODEL;
D O I：
10.1177/2045125317727260
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [21] Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient
    Lommer, Kilian
    Tutzer, Franziska
    Hofer, Alex
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (04) : 288 - 290
  • [22] Cariprazine and clozapine combination for the treatment of psychosis in a young, female patient with schizophrenia: a case report
    Dmuhovskis, Anzejs
    Taube, Maris
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [23] Cariprazine on Psychosis: Beyond Schizophrenia - A Case Series
    Bajouco, Miguel
    Mota, David
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1351 - 1362
  • [24] Cariprazine (Vraylar) for Schizophrenia and Bipolar I Disorder
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1493): : 51 - 53
  • [25] Akathisia during cariprazine treatment: Post-hoc analyses of pooled schizophrenia studies
    Barabassy, A.
    Sebe, B.
    Szatmari, B.
    Laszlovszky, I.
    Harsanyi, J.
    Acsai, K.
    Seregi, B.
    Earley, W.
    Patel, M.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S323 - S323
  • [26] Cariprazine switch experiences in patients with recurrent schizophrenia
    Vita, Antonio
    Ceraso, Anna
    Valsecchi, Paolo
    RIVISTA DI PSICHIATRIA, 2019, 54 (06) : S16 - S19
  • [27] Update on schizophrenia and bipolar disorder: focus on cariprazine
    Roberts, Rona Jeannie
    Findlay, Lillian Jan
    El-Mallakh, Peggy L.
    El-Mallakh, Rif S.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1837 - 1842
  • [28] Efficacy of cariprazine in the treatment of negative symptoms of schizophrenia: Post hoc analyses versus aripiprazole
    Barabassy, A.
    Szatmari, B.
    Laszlovszky, I.
    Harsanyi, J.
    Acsai, K.
    Sebe, B.
    Earley, W.
    Patel, M.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S417 - S418
  • [29] Cariprazine as a therapeutic option for schizophrenia: a drug evaluation
    Mucci, Federico
    Della Vecchia, Alessandra
    Baroni, Stefano
    Marazziti, Donatella
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 415 - 426
  • [30] Treatment of schizophrenia negative symptoms: Future prospects
    Erhart, SM
    Marder, SR
    Carpenter, WT
    SCHIZOPHRENIA BULLETIN, 2006, 32 (02) : 234 - 237
12345